Mar 31, 20212:00 PM - 3:30 PM
ACS Webinar - An Integrated Approach: Oral Delivery of a Fatty Acid Acylated GLP-1 Peptide
Join Stephen Buckley of Novo Nordisk for an in-depth overview of the integrated approach employed in the discovery and development of oral semaglutide, a GLP-1 analogue coformulated with the absorption enhancer sodium N-[8-(2-hydroxybenzoyl) aminocaprylate] (SNAC) in a tablet.